Friedman Franklin Stuart 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Nov 26, 2019
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-11-25+24,000→ 24,000 totalExercise: $48.44Exp: 2029-11-25→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option will vest in equal monthly installments over a three-year period, subject to a continued service relationship through such dates.